The isolated vascularly perfused rat intestine exhibits an obligatory need for a protein carrier in order to absorb zinc. Therefore this system is ideal for use as a model to identify the plasma carrier during zinc absorption. Affinity chromatography on Blue Sepharose CL-6B was employed to separate the major serum zinc-binding proteins in the portal effluent of the perfused intestine. It was found that 94% of newly absorbed 65Zn was transported in the portal serum-containing perfusate as an albumin-65Zn complex. The identity of albumin as the plasma carrier was confirmed by polyacrylamide-slab-gel electrophoresis. This evidence suggests that albumin is the plasma protein that is involved in removal of zinc from intestinal-mucosal cells and subsequent transport of the metal in portal blood to the liver.
The mechanism of the zinc-absorption process has not been fully elucidated. However, it is clear that once dietary zinc is taken up from the lumen into intestinal-mucosal cells it is either integrated into intracellular zinc pool(s) or is rapidly (within minutes) transported across the basolateral membrane to the plasma compartment (Davies, 1973; Smith et al., 1978; Cousins, 1979a,b) .
In plasma, zinc has been found to be associated with albumin, a2-macroglobulin, transferrin and amino acids (Vikbladh, 1951; Parisi & Vallee, 1970; Boyett & Sullivan, 1970; Prasad & Oberleas, 1970) . However, it has repeatedly been shown that albumin is the major plasma protein with which zinc is associated during systemic transport. In contrast, it has been suggested that newly absorbed zinc in portal plasma is transported from the intestine as a zinctransferrin complex (Evans & Winter, 1975; Evans, 1976 ). Recently we have been using an intestinalperfusion technique, in which the lumen and vascular supply of the rat small intestine are simultaneously perfused, to examine the characteristics and regulatory aspects of zinc absorption (Smith et al., 1978) . This isolated system offers the unique opportunity to examine the vascular carrier in greater detail than is possible in intact-animal experiments. Moreover, we have utilized affinity chromatography on Blue Sepharose CL-6B (Travis & Pannell, 1973;  Wille, 1976) to fractionate the serum proteins in the vascular effluent of the perfused intestine. This method of Vol. 184 serum-protein fractionation has eliminated the need for ion-exchange-chromatographic procedures, which may not be compatible with the metal-binding properties of the carrier protein(s) involved. In the present paper, we demonstrate that newly absorbed zinc in the portal effluent of the isolated perfused rat intestine is transported by albumin.
Materials and Methods

Animals
Male rats (Sprague-Dawley strain, 150-200g; Charles River, Wilmington, MA, U.S.A.) were fed on a standard commercial diet (Ralston Purina Co., St. Louis, MO, U.S.A.) and tap water ad libitum.
Reagents and materials
All chemicals were reagent grade. Buffers and reagents were prepared in water that was glassdistilled and then deionized (Ultrapure-Barnstead Co., Framingham, MA, U.S.A.). 65Zn (carrier-free) and 59FeC13 (20mCi/mg) were purchased from New England Nuclear Corp., Boston, MA, U.S.A. M-199 tissue-culture medium and high-molecularweight dextran (mol.wt. 70000-90000) were from GIBCO, Grand Island, NY, U.S.A. Blue Sepharose CL-6B, Sephadex 
Intestinal perfusion
All rats were deprived of food for 18-24h before surgery. The intestinal isolation and perfusion procedure is described in detail elsewhere (Smith et al., 1978) . The lumen perfusate was lOml of modified M-199 tissue-culture medium. The zinc content of this medium was elevated to 0.75mm with ZnSO4; 250Ci of carrier-free 65Zn was added to each lOml portion 1 h before use. In some perfusions 25,uCi of 59FeCl3 was added to the perfusate in place of 65Zn.
The standard vascular perfusate was composed of Krebs-Ringer bicarbonate buffer containing 5% rat serum, 4.7 % high-molecular-weight dextran, 0.1 % glucose and dexamethasone (25,ug/lOOml) (Smith et al., 1978) . After the 1 h perfusion period, samples of the vascular perfusate, which were collected as fractions (7.0ml), were counted for 65Zn or 59Fe radioactivity with a Beckman 4000 gamma spectrometer [7.6cm (3in) crystal; Beckman Instruments, Fullerton, CA, U.S. A.] .
The composition of the vascular perfusate was modified to examine the influence of specific components on zinc absorption. In some experiments normal rat serum was replaced with serum that had first been dialysed and then equilibrated with excess iron by the method of Ramsay (1953) , in order to saturate transferrin with iron. In other experiments, serum was first dialysed against 0.9% NaCl in 50mM-Hepes buffer (pH7.4) for 48h before the vascular perfusate was prepared. Alternatively, rat serum albumin, which was prepared by Sephadex G-200 gel-filtration chromatography followed by DEAE-Sephadex ion-exchange chromatography (Killander, 1964) , was substituted for serum in the perfusate in an amount (2.5mg/ml) equivalent to that found in perfusate containing 5% serum. A final series of perfusions was conducted with serumfree perfusate made iso-osmotic by adjusting the amount of high-molecular-weight dextran initially added to the perfusate solution.
Analysis of the vascular perfusate by Blue Sepharose chromatography Portions (4ml) of those fractions of vascular effluent with the most radioactivity, thus indicating maximum absorption, were desalted by passage through a Sephadex G-25 column (1.5cmx30cm), equilibrated with SOmM-Tris/HCl/50mM-KCl, pH 7.0 (buffer A). Fractions containing material excluded by the gel were analysed for 65Zn or 59Fe content, pooled and applied to a column (1.5cmx30cm) of Blue Sepharose CL-6B that was prepared and equilibrated with buffer A. Blue Sepharose is an affinity gel that selectively removes albumin, while transferrin and a2-macroglobulin pass through the column. The column was washed with 50ml of buffer A. Next, bound albumin was eluted by passing 50ml of 50mM-Tris/HCl/1.SM-KCl, pH7.0 (buffer B) through the column. The 65Zn or 59Fe content of all fractions (2.5ml each) was measured as described above.
To verify the identity of albumin as the 65Zn-binding species eluted with buffer B, the 65Zn-containing fractions were pooled, concentrated by ultrafiltration and subjected to electrophoresis on a 10% polyacrylamide slab gel (6 % stacking gel), at 120V for 3 h, by the method of Laemmli (1970) (Killander, 1964) . Fractions containing these proteins were pooled and dialysed overnight at 4°C against 50mM-Tris/HCI, pH 7.0. The dialysed sample was applied to a column (l.5cm x 30cm) of DEAE-Sephadex A-50. The proteins were eluted with a linear gradient (250ml) of 50-500mM-Tris/HCI, pH7.4.
In another experiment 10mg of rat albumin (prepared as described above) was dissolved in 50mM-Tris/HCI/50mM-NaCl (pH7.4) and incubated with 1JpCi of 65Zn for 2h at 4°C. The mixture was passed through a column (1.5cm x 30cm) of Sephadex G-25 (in the same buffer) and the void-volume fractions were collected. These fractions were pooled and subjected to ion-exchange chromatography on DEAE-Sephadex as described above.
In some experiments the portal vein of rats was cannulated 15min after 5OpCi of 65Zn was placed in the intestinal lumen. A total of 3.Oml of blood was collected, allowed to clot and then centrifuged at 12000g (ray. 8.0cm, 10min) to obtain the serum. The serum was then sequentially fractionated on Sephadex G-200 and DEAE-Sephadex as described above. These fractionation procedures were also used to fractionate the vascular perfusate in one series of experiments. The perfusion was carried out as described in the preceding section, except that 50,uCi of 65Zn was used in the lumen perfusate.
Results
The effect on the 65Zn-absorption process in the perfused rat intestine, when modifications were made in the composition of the vascular perfusate, is illustrated in Fig. 1 . Approx. 2% of the available 65Zn in the lumen was transferred to the vascular perfusate when the latter contained 5 % rat serum. However, no transfer was observed when serum was not present in the vascular perfusate. These data demonstrate the need for a serum carrier in the vascular supply in order to transport newly absorbed zinc from intestinal-mucosal cells. On the other hand, when purified rat serum albumin alone was added to the perfusate, there was an increase in 65Zn absorption which greatly exceeded the value observed with serum containing the same quantity of albumin. This increase might be explained in part by the fact that during the preparation of albumin by DEAESephadex chromatography zinc is removed from the protein (discussed below).
Dialysed serum had no significant effect on zinc absorption by the perfused rat intestine. Similarly, when the vascular perfusate contained serum to which excess iron had been added in order to saturate the iron-transport protein transferrin, no effect on 65Zn absorption was observed. These perfusion data indirectly suggest that albumin is the carrier protein involved in the transport of newly absorbed zinc.
Affinity chromatography on Blue Sepharose CL-6B was used for the selective removal of albumin from the vascular effluent of the isolated intestine.
Perfusates containing 59Fe or 65Zn were taken directly from the portal-vein cannulation and passed through a Sephadex G-25 column for removal of low-molecular-weight substances. Fraction no. Fig. 2 . Blue Sepharose CL-6B chromatography of vascular perfusates during (a) 59Fe or (b) 65Zn absorption Vascular perfusions were carried out as described in the Materials and Methods section. Perfusates containing 65Zn or 59Fe were first desalted by passage through a Sephadex G-25 column (1.5cmx30cm) eluted with 50mM-TrisfHCI, pH7.0. The fractions excluded from this gel were pooled and applied to a column (1.5cmx30cm) of Blue Sepharose CL-6B. After a 50ml wash with 50mM-Tris/HCI/50mM-KCI, pH7.0, the bound material was eluted with 50ml of 50mM-Tris/HCI/1.5 M-KCI, pH 7.0. Fractions (2.5 ml) were collected. column (1.5cmx30cm) of Blue Sepharose CL-6B, equilibrated with low-KCI buffer (buffer A). Albumin binds to the immobilized dye on the gel matrix, whereas transferrin does not bind and passes through the column. The column was subsequently eluted with high-KCI buffer (buffer B), which removes albumin from binding sites on the gel (Fig. 2) in the vascular perfusate was eluted with transferrin in the low-KCI buffer. In contrast, when 65Zn was added to the lumen perfusate, 94 % of the 65Zn in the vascular perfusate which was applied to the column was eluted from the affinity column with the high-KCI buffer, i.e. with albumin (65Zn recovery> 90%). These data demonstrate the resolving power of the vascular perfusion procedure, since it clearly is able to discriminate between the different carriers for iron and zinc. Polyacrylamide-slab-gel electrophoresis of the 65Zn-albumin peak from Blue Sepharose chromatography yielded one major band, which exhibited the same mobility as commercially prepared albumin (Fig. 3) .
A markedly different distribution of 65Zn among the serum proteins was observed when they were fractionated by DEAE-Sephadex ion-exchange chromatography. When serum was removed from the portal vein of intact rats, in which 65Zn was placed in the intestinal lumen and subsequently chromatographed on Sephadex G-200, 95 % of the 65Zn applied to the column was recovered with the albumin-transferrin fractions. However, when those fractions were placed on a DEAE-Sephadex column, 65Zn was eluted at the same concentration of chloride, as is transferrin (Fig. 4a) . Moreover, only 18 % of the 65Zn applied to this column was recovered; 70 % of this was as transferrin.
Similarly when 65Zn-labelled serum proteins in the vascular perfusate were subjected to the combination of gel filtration and ion-exchange chromatography substantial losses were noted during the latter (Fig. 4b) . In this case total recovery from the DEAESephadex column was 30%, of which 81 % was recovered with the transferrin fractions.
The migration of 65Zn-labelled albumin and 59Fe-labelled serum is shown in Fig. 5 . It is clear that 65Zn does not migrate to any appreciable amount with albumin during DEAE-Sephadex chromatography. Since the 65Zn-albumin complex was first passed through Sephadex G-25 to remove free 65Zn, it appears that DEAE-Sephadex chromatography alters the conditions necessary to maintain zinc and albumin as a complex. 59Fe-labelled serum proteins were eluted to show the position of transferrin (Fig.  Sa) . A comparison of the two profiles shows that a large portion of the 65Zn from the 65Zn-albumin complex is eluted at a concentration similar to that required for transferrin elution (Fig. 5b ).
Discussion
The experiments described here provide direct evidence that zinc is transported from the intestine as a 65Zn-albumin complex. These results are in agreement with the widely held hypothesis that circulating zinc is transported mainly by albumin (Boyett & Sullivan, 1970; Prasad & Oberleas, 1970) . However, our observations are in direct contrast with other data (Evans & Winter, 1975; Evans, 1976) Fractions were analysed for A254 (e) and 65Zn (o). Fraction size was 3.Oml.
that transferrin is the carrier of newly absorbed zinc in the portal plasma. The reason for this discrepancy may lie in the nature of zinc-albumin binding and the chromatographic methodology used. The loose association between zinc and albumin does not appear to withstand DEAE-Sephadex ion-exchange chromatography, the standard technique used for separation of transferrin and albumin. We found that losses of zinc from albumin were extensive (>80%) when 65Zn-albumin complexes were subjected to DEAE-Sephadex chromatography (Fig. 4) . These observations may explain the results obtained by Evans (1976) The role of albumin in zinc transport in portal plasma is supported on the basis of the relative concentrations of albumin and transferrin in plasma. These proteins account for approx. 55 and 3 % of the total protein content of plasma respectively (Boyett & Sullivan, 1970; Prasad & Oberleas, 1970) . In this regard Evans (1976) has shown in vitro that apotransferrin would bind twice as much 65Zn from labelled basolateral membranes of intestinal cells as would metal-free albumin. Nevertheless, considering the 18-fold higher concentration of albumin relative to transferrin in plasma, more than 85 % of the plasma zinc would be predicted to be carried by albumin, although zinc is more tightly bound to transferrin.
Our observation that purified albumin can transport more zinc from the perfused intestine, compared with serum with a comparable amount of albumin, supports a zinc-transport role for this plasma protein. . Ion-exchange chromatography of rat serum and purified rat albumin Rat serum was labelled with 59Fe and a purified rat albumin-65Zn complex was prepared as described in the Materials and Methods section. (a) The 59Fe-labelled serum was first passed through a Sephadex G-200 column. "9Fe-labelled transferrin and albumin were eluted as a single peak. Those fractions were pooled and dialysed overnight against 50mM-Tris/HCI, pH 7.0. (b) The 65Zn-albumin complex was first passed through a column of Sephadex G-25. DEAE-Sephadex ion-exchange chromatography was carried out on both samples on a 1.5cm x 30cm column with a linear gradient --; 50-500mM-Tris/HCI, pH 7.0). All fractions were analysed for A254 (M) and 59Fe or 65Zn (0). Fraction size was 3.Oml.
Since this rat albumin sample was prepared by DEAE-Sephadex chromatography, appreciable losses of zinc would be expected. This in turn would increase the number of zinc-binding sites available in the vascular perfusate. The relationship of these zincbinding sites to absorption has important clinical implications. For example, the decrease in zinc status associated with liver dysfunction and hypoalbuminaemia (Underwood, 1977) could be explained in part on the basis of a reduction in absorption. In addition, the data presented above demonstrating the lack of absorption when albumin is deleted from the vascular perfusate suggests that absorption may be diminished in patients maintained on extensively diluted blood plasma.
